Skip to main content
. 2022 Feb 2;8(3):FSO783. doi: 10.2144/fsoa-2021-0126

Table 2. . Health characteristics of study sample (n = 113).

Characteristic Observations, n (%) p-value
  ICU patients (n = 55) Wards patients (n = 58)  
Hypertension 37 (67.3) 31 (53.4) 0.155
Diabetes mellitus 35 (63.6) 26 (44.8) 0.062
Nonhematologic cancer, on chemotherapy 0 (0) 1 (1.7) >0.999
Nonhematologic cancer, not on chemotherapy 0 (0) 1 (1.7) >0.999
Hematologic cancer, on chemotherapy 0 (0) 1 (1.7) >0.999
Hematologic cancer, not on chemotherapy 0 (0) 0 (0)
Use of anti-hypertensive medications      
Calcium channel blocker 13 (23.6) 9 (15.5) 0.312
Beta blocker 14 (25.5) 13 (22.4) 0.739
ACE-inhibitor use 25 (45.5) 17 (29.3) 0.065
Diuretic 14 (25.5) 7 (12.1) 0.081
Central agonist 1 (1.8) 0 (0) 0.955
Vasodilator 3 (5.5) 1 (1.7) 0.533
Use of disease modifying anti-rheumatic drugs 2 (3.6) 0 (0) 0.213
Current smoker 4 (7.3) 7 (12.1) 0.131
Pregnant 0 (0) 2 (3.4) 0.499
Mortality 22 (40.0) 4 (6.9) <0.0001

p-value significance is set at 0.05. p-values from Mann–Whitney test for continuous variables and chi-squared test for categorical variables.

ACE: Angiotensin-converting enzyme; ICU: Intensive care unit; M: Mean; SD: Standard deviation.